Published in Br J Haematol on April 01, 1975
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest (1976) 1.67
Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol (2009) 1.64
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest (1981) 1.62
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent. J Clin Invest (1981) 1.44
Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest (1978) 1.22
Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest (1978) 1.14
Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest (1986) 1.13
The interaction of bovine factor VIII with human platelets. J Clin Invest (1975) 1.04
The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility. J Clin Invest (1978) 1.01
Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets. J Clin Invest (1984) 0.87
Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI. J Clin Invest (1979) 0.80
Evidence that a 210,000-molecular-weight glycoprotein (GP 210) serves as a platelet Fc receptor. J Clin Invest (1987) 0.79
8-BuS-ATP derivatives as specific NTPDase1 inhibitors. Br J Pharmacol (2013) 0.77
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med (1996) 6.79
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax (2008) 4.78
Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem (1991) 3.93
The biology of natural transformation. Annu Rev Microbiol (1986) 3.46
New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council. Med J Aust (1997) 2.69
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax (2004) 2.45
Retinal arterial obstruction in children and young adults. Ophthalmology (1981) 2.45
Venous air embolism from central venous catheterization: a need for increased physician awareness. Crit Care Med (1999) 2.41
The influence of positive affect on the unusualness of word associations. J Pers Soc Psychol (1985) 2.40
Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38
Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood (1980) 2.22
Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med (1980) 2.07
Prevalence of tuberculosis infection among primary school-entry children in Sydney. Aust N Z J Public Health (1996) 2.06
1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet (1977) 2.06
Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities. Br J Haematol (1972) 2.06
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J (1971) 2.04
The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet (1985) 1.96
Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A (1998) 1.92
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature (1987) 1.91
The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood (1975) 1.87
Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med (1974) 1.86
The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1999) 1.71
Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest (1999) 1.71
Nerve extract induces increase and redistribution of acetylcholine receptors on cloned muscle cells. Proc Natl Acad Sci U S A (1978) 1.67
Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin. J Clin Invest (1978) 1.66
Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci U S A (1993) 1.66
Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem (1981) 1.62
Letter: A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh (1975) 1.59
A rapid method for removal of [125I]iodide following iodination of protein solutions. Anal Biochem (1980) 1.56
Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol (1977) 1.56
VERO cells (Cercopithecus aethiops kidney)--growth characteristics and viral susceptibility for use in diagnostic virology. (Brief report). Arch Gesamte Virusforsch (1969) 1.50
Domestic violence in a primary care setting. Patterns and prevalence. Arch Fam Med (1995) 1.48
Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol (1974) 1.48
The relationship between quality of life and self-determination: an international study. J Intellect Disabil Res (2005) 1.47
Evaluation of automated large-scale screening tests for syphilis. J Clin Pathol (1976) 1.46
Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol (1984) 1.44
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42
The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin). Biochem Biophys Res Commun (1983) 1.42
The effects of endotoxin on vascular endothelium. J Exp Med (1969) 1.42
Protein kinase C is not necessary for transforming growth factor beta-induced growth-arrest in leukemia cell lines. Leuk Res (1997) 1.41
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. J Antimicrob Chemother (1994) 1.39
SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens (2007) 1.38
Genetic exchange in the environment. Antonie Van Leeuwenhoek (1989) 1.38
A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A (2001) 1.35
Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood (1981) 1.34
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
Screening tests for syphilis. A comparison of the Treponema pallidum haemagglutination assay with two automated serological tests. Br J Vener Dis (1977) 1.30
Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med (2001) 1.29
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 1.27
Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res (1974) 1.26
Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr (2000) 1.26
Prevention and treatment of catheter-associated urinary tract infections. J Infect (1985) 1.26
Blood platelet nucleotides in man and other species. Nature (1969) 1.24
Food practices and preferences of some college students. J Am Diet Assoc (1970) 1.23
Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multidrug-resistant, gram-negative bacilli. Antimicrob Agents Chemother (1980) 1.23
Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet (1994) 1.22
Detection and determination of adenosine diphosphate and related substances in plasma. Biochem J (1966) 1.20
Haemophilus influenzae and genital tract infections in children. Acta Paediatr Scand (1987) 1.19
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med (2000) 1.18
Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17
The platelet defect associated with albumism. Br J Haematol (1972) 1.17
Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem (1989) 1.17
Retracted Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem (2000) 1.16
Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 1.14
Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest (1978) 1.14
Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood (1985) 1.13
Acquired qualitative platelet disorders. Clin Haematol (1983) 1.13
Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis. Am Rev Respir Dis (1987) 1.13
The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J (2002) 1.13
Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon. Tubercle (1986) 1.12
Enzyme replacement in nervous tissue after allogeneic bone-marrow transplantation for fucosidosis in dogs. Lancet (1986) 1.12
Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L1 layer of Mycobacterium intracellulare serovar 20. Infect Immun (1986) 1.12
Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J (2002) 1.12
Evidence for an active role of donor cells in natural transformation of Pseudomonas stutzeri. J Bacteriol (1983) 1.11
HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis. Ann Neurol (1978) 1.10
Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol (1994) 1.10
Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther (2000) 1.10
Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry (1990) 1.10
Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells. J Med Virol (1995) 1.10
Platelet antiheparin activity: storage site and release mechanism. Blood (1974) 1.10
Platelets and the vessel wall: how much aspirin? Lancet (1980) 1.09
The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem J (1967) 1.09
Infection and multiple sclerosis--a new hypothesis? J Neurol Neurosurg Psychiatry (2002) 1.08
The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett (1992) 1.08
Improved media for the culture of Neisseria gonorrhoeae. J Med Microbiol (1980) 1.07
2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest (1983) 1.07